Overview

Ashwagandha for Cognitive Dysfunction

Status:
Not yet recruiting
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
This is a 1:1 randomized double blinded placebo controlled trial. The primary objective is to determine if ashwagandha can improve cognitive dysfunction when compared with placebo in patients undergoing chemotherapy for breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Sutter Health